(Q33146911)

22 July 2017

1 reference

title

Medical therapy of pulmonary hypertension. Conventional therapies (English)

1 reference

22 July 2017

R Naeije

1

1 reference

PubMed ID

11590845

22 July 2017

J L Vachiéry

series ordinal

2

1 reference

22 July 2017

1 September 2001

1 reference

Clinics in Chest Medicine

22 July 2017

1 reference

22 July 2017

22

1 reference

22 July 2017

3

1 reference

22 July 2017

517-527

1 reference

Partitioning of pulmonary vascular resistance in primary pulmonary hypertension.

22 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970288-4

7 January 2021

Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970288-4

7 January 2021

The cardiopulmonary and renal hemodynamic effects of norepinephrine in canine pulmonary embolism.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970288-4

7 January 2021

Vasodilator therapy for primary pulmonary hypertension in children

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970288-4

7 January 2021

Survival in primary pulmonary hypertension with long-term continuous intravenous prostacyclin

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970288-4

7 January 2021

A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970288-4

7 January 2021

Regression of primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970288-4

7 January 2021

Stimulus-response curve of hypoxic pulmonary vasoconstriction in intact dogs: effects of ASA

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970288-4

7 January 2021

Survival in patients with primary pulmonary hypertension. Results from a national prospective registry.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970288-4

7 January 2021

Mechanisms of gas exchange abnormality in patients with chronic obliterative pulmonary vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970288-4

7 January 2021

Primary pulmonary hypertension. I. Clinical and hemodynamic study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970288-4

7 January 2021

Primary pulmonary hypertension: natural history and the importance of thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970288-4

7 January 2021

Single- versus double-lung transplantation for pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970288-4

7 January 2021

26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 1: congenital heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970288-4

7 January 2021

The pathology of hypertensive pulmonary vascular disease; a description of six grades of structural changes in the pulmonary arteries with special reference to congenital cardiac septal defects

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970288-4

7 January 2021

Long-term treatment of primary pulmonary hypertension with continuous intravenous epoprostenol (prostacyclin)

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970288-4

7 January 2021

Venous thromboembolism

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970288-4

7 January 2021

The pressure-flow response of the pulmonary circulation in patients with heart failure and pulmonary vascular disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970288-4

7 January 2021

Primary pulmonary hypertension in children living at high altitude

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970288-4

7 January 2021

Possible association between maternal indomethacin therapy and primary pulmonary hypertension of the newborn

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970288-4

7 January 2021

Effect of digoxin on right ventricular function in severe chronic airflow obstruction. A controlled clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970288-4

7 January 2021

Adenosine as a vasodilator in primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970288-4

7 January 2021

Pulmonary circulation at high altitude

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970288-4

7 January 2021

Preflight medical screening of patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970288-4

7 January 2021

High-altitude pulmonary edema with primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970288-4

7 January 2021

Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Nocturnal Oxygen Therapy Trial Group

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970288-4

7 January 2021

Successful management of labor and delivery in primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970288-4

7 January 2021

Oral contraceptives and progressive pulmonary vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970288-4

7 January 2021

Inhaled iloprost to treat severe pulmonary hypertension. An uncontrolled trial. German PPH Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970288-4

7 January 2021

Primary pulmonary hypertension. Vascular structure, morphometry, and responsiveness to vasodilator agents.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970288-4

7 January 2021

Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970288-4

7 January 2021

Histopathology of primary pulmonary hypertension. A qualitative and quantitative study of pulmonary blood vessels from 58 patients in the National Heart, Lung, and Blood Institute, Primary Pulmonary Hypertension Registry

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970288-4

7 January 2021

Exercise and heart failure. A review

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970288-4

7 January 2021

Clinical significance of the pulmonary vasodilator response during short-term infusion of prostacyclin in primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970288-4

7 January 2021

Hope in primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970288-4

7 January 2021

High-dose calcium channel-blocking therapy for primary pulmonary hypertension: evidence for long-term reduction in pulmonary arterial pressure and regression of right ventricular hypertrophy.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970288-4

7 January 2021

Magnitude and implications of spontaneous hemodynamic variability in primary pulmonary hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970288-4

7 January 2021

Primary pulmonary hypertension. A national prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970288-4

7 January 2021

The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970288-4

7 January 2021

The short-term effects of digoxin in patients with right ventricular dysfunction from pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970288-4

7 January 2021

Inhaled nitric oxide in primary pulmonary hypertension: a safe and effective agent for predicting response to nifedipine

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970288-4

7 January 2021

Echocardiographic characterization of the improvement in right ventricular function in patients with severe pulmonary hypertension after single-lung transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970288-4

7 January 2021

Primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970288-4

7 January 2021

Prostacyclin-induced acute pulmonary vasodilation in primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970288-4

7 January 2021

Graded balloon dilation atrial septostomy in severe primary pulmonary hypertension. A therapeutic alternative for patients nonresponsive to vasodilator treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970288-4

7 January 2021

Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension. A dose-response study and comparison with prostacyclin.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970288-4

7 January 2021

Inhaled nitric oxide as a screening agent for safely identifying responders to oral calcium-channel blockers in primary pulmonary hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970288-4

7 January 2021

Long-term oxygen therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970288-4

7 January 2021

The pathophysiology of failure in acute right ventricular hypertension: hemodynamic and biochemical correlations.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970288-4

7 January 2021

The acute administration of vasodilators in primary pulmonary hypertension. Experience from the National Institutes of Health Registry on Primary Pulmonary Hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970288-4

7 January 2021

Pulmonary hypertension with special reference to the vasoconstrictive factor

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970288-4

7 January 2021

10.1016/S0272-5231(05)70288-4

Identifiers

DOI

1 reference

22 July 2017

1 reference

PubMed ID

11590845